3 HOS~ital, Basel, Switzerland. Thiamine (Th) dependent pyruvatedehydroqenase (PDH) deficiency. The biochemical abnormalities in vitamine dependencies are poorly understood. Defects of coenzyme synthesis or transport improved by mass action, compensation of decreased affinity of the apoenzyme for its coenzyme and stabilization of a mutant apoenzyme by high concentrations of coenzyme are some of the mechanisms discussed. -Fibroblast cultures from two children suffering from congenital lactic acidosis responding well to very high doses of Th (50 -100 mg/kg/d) were studied. Reduced C02-production from 1,14~-pyruvate and deficient activity of PDH-complex were found. Culture of these fibroblasts in the presence of high concentrations of Th (0.4 pq/ml) resulted in stimulation (20 -100 %) of pyruvate decarboxylation in both systems. This effect could not be prevented by puromycin (50 pg/ml), an inhibitor of protein synthesis. Surprisingly the same result was also obtained in normal cell lines. Furthermore the same effect could also be demonstrated for 2-oxoglutaricaciddehydrogenase and for 2-0x0-isocaproicaciddehydrogenase. -The type of activation mechanism involved is not yet clear. In the case of PDH activation might be due to the conversion of the enzyme comolex to the dephosphorylated (i.e. activated) form by high concentrations of thiaminepyrophosphate. The clinically relevant conc1.usion is that in any Datient with a partial deficiency of one of these dehydroqenases a therapeutic trial with very high doses of Th is warranted. 299: 1365, 1978) .In a 12 year-old boy with CLA, DCA was admi--nistered orally during 12 months. The underlying biochemical defect in this patient is still unkown. In cultured fibroblasts, enzymatic activities of pyruvate dehydrogenase(PDH) , pyruvate carboxvlase. ~hos~hoenol~vruvate carboxvkinase were within the norm ale range.'^^^' therap;-given at a doie as low as 15 mglkg b.d. every second day, was effective in lowering plasma lactate (7.6 mMol. to 0.9 mMol). In addition growth rate was stimulated (7 cmlyear). Routine serial analysis were made throughout the study including blood levels of glucose, lipids, ketones, uric acid, oxalic aciduria, and the search of renal, hepatic, ocular and neural dysfunction. No adverse physical or biological effects associated with DCA therapy were observed. However DCA was not more effective on the gradually deteriorating neurological condition of this child than previous therapeutic attempts with thiamine, biotine, lipoic acid and ketonemic diet. We conclude that the return to normal of lactate levels was probably secondary to the activation of muscular PDH; it is not clear whether the neurological disorder is related to abnormal levels of a metabolite in the plasma. A direct immunofluorescence staining of either T or B lymphocyte membrane markers was combined with a quinacrine staining for the Y-chromatin in the interphase nuclei of these cells. In this way it was possible to identify the origin of both lymphocytic populations in the peripheral blood after a successful bone marrow transplantation from a donor of the opposite sex in 2 patients with severe combined immunodeficiency (SCID) and in 8 patients with aplastic anemia (AA). The findings were correlated with the results of karyotyping following PHA stimulation of (T) lymphocytes and with the serum Ig allotypes. In the 2 SCID patients T cells of donor origin were found together with B cells of recipient origin. In one of these patients both donor (G3m (c3)(c5)) and recipient (G2m (n)) Ig allotypes were produced by the recipient following innnunological reconstitution, indicating the presence of both donor and recipient B cell populations. In the 8 patients with AA both T and B cell lineages were of donor origin except in 2 patients in whom by the combined staining technique an indication was found for partial T cell chimerism. One of them had different Ig allotypes as compared with the donor, but still produced recipient Ig type (Glm (a)(x)(z), G3m (g)) at more than one year after transplantation indicating also the presence of the donors' and the patients' B cell population. The leucocytes in the breast milk of 14 mothers 2-5 days following delivery were studied.Tota1 white cell counts ranged from 16.000/ml to 2.400.000/ml. 
